Sign Up to like & get
recommendations!
0
Published in 2022 at "Bioengineered"
DOI: 10.1080/21655979.2021.2022263
Abstract: ABSTRACT Cholangiocarcinoma is a common malignant tumor. Advanced treatment is difficult and the prognosis is poor. It is of great significance to find an effective method to treat cholangiocarcinoma and improve the prognosis of patients.…
read more here.
Keywords:
patients cholangiocarcinoma;
seed stent;
i125 seed;
stent implantation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Gastroenterology Report"
DOI: 10.1093/gastro/goy049
Abstract: Abstract Background and objective Although pre-operative biliary drainage (PBD) is frequently performed in patients with cholangiocarcinoma (CCA), its impact on patient survival is unclear. Our aim was to evaluate the impact of PBD on overall…
read more here.
Keywords:
operative biliary;
pre operative;
drainage;
patients cholangiocarcinoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of International Medical Research"
DOI: 10.1177/0300060520976864
Abstract: Objective This study aimed to investigate the expression of O-linked glycoprotein glycans in tissue of patients with cholangiocarcinoma compared with adjacent normal tissue. Methods Sixty patients with cholangiocarcinoma were included in the study. Permethylated O-linked…
read more here.
Keywords:
linked glycans;
tissue;
patients cholangiocarcinoma;
expression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.588
Abstract: 588Background: Most cholangiocarcinoma (CCA) patients (pts) are diagnosed with advanced disease and are ineligible for surgery. FGFR2 fusions or rearrangements are present in 10–16% of pts with int...
read more here.
Keywords:
survival patients;
free survival;
fusions rearrangements;
patients cholangiocarcinoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2022.766023
Abstract: Gemcitabine and cisplatin serve as appropriate treatments for patients with cholangiocarcinoma (CCA). Our previous study using histoculture drug response assay (HDRA), demonstrated individual response patterns to gemcitabine and cisplatin. The current study aimed to identify…
read more here.
Keywords:
patients cholangiocarcinoma;
patients cca;
metabolic phenotyping;
gemcitabine cisplatin ... See more keywords